Pradeep Shahi
Overview
Explore the profile of Pradeep Shahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manchanda Y, Jones B, Carrat G, Ramchunder Z, Marchetti P, Leclerc I, et al.
bioRxiv
. 2025 Jan;
PMID: 39868265
The use of incretin analogues has emerged in recent years as an effective approach to achieve both enhanced insulin secretion and weight loss in type 2 diabetes (T2D) patients. Agonists...
2.
Nagpal S, Png Yi Jie J, Malinovskaya J, Kovshova T, Jain P, Naik S, et al.
ACS Nano
. 2024 Feb;
18(8):6162-6175.
PMID: 38359902
Nanomedicines exhibit multifaceted performances, yet their biopharmaceutics remain poorly understood and present several challenges in the translation from preclinical to clinical research. To address this issue and promote the production...
3.
Bhowmik S, Bhowmick S, Maiti K, Chakra A, Shahi P, Jain D, et al.
Cancer Chemother Pharmacol
. 2018 Jul;
82(3):521-532.
PMID: 29995186
Purpose: To compare the pharmacokinetic bioequivalence and safety of a generic pegylated liposomal doxorubicin formulation (SPIL DXR hydrochloride liposome injection) with that of the reference products, Caelyx or Doxil. Methods:...
4.
Bhowmik S, Bhowmick S, Maiti K, Chakra A, Shahi P, Rajamannar T
Leuk Lymphoma
. 2017 Oct;
59(6):1478-1481.
PMID: 28994344
No abstract available.
5.
Thennati R, Khanna A, Khanna M, Sonaiya T, Mehta T, Mehta K, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
3(6):428-38.
PMID: 27129118
A novel corticosteroid compound (short form of IUPAC name: SFDAC) has been discovered by Sun Pharma Advanced Research Company (SPARC) Ltd. A randomized, observer-blind, active-controlled, parallel-groups, intranasal multiple escalating dose...